Skip to content
DataLookout
Menu

NefPONCT04576078

Post-operative Analgesic Effect of Oral Nefopam

StatusActive, Not Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 10 words
    • Enrollment closed, study ongoing
    • Secondary endpoints: details revised at 4 of 13 entries
    • Site details revised
  2. Notable Primary completion date: Jun 30, 2026 to Dec 30, 2026
    • Enrollment target: 40 to 50
    • Study completion date: Nov 15, 2026 to May 15, 2027
    • Site details revised
    v5
  3. Notable Primary completion date: Jun 30, 2024 to Jun 30, 2026
    • Study completion date: Nov 15, 2024 to Nov 15, 2026
    v4
  4. Notable Enrollment target: 58 to 40v3 Show 4 more changesShow less
    • Primary completion date: Jul 30, 2023 to Jun 30, 2024
    • Eligibility criteria revised
    • Study completion date: Nov 15, 2023 to Nov 15, 2024
    • Secondary endpoints: 12 to 13
  5. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Oct 2022 to Jul 30, 2023
    • Start date changed from estimate of Oct 2020 to Jun 29, 2021
    • Study sites: 0 to 1
    • Study completion date: Feb 2023 to Nov 15, 2023
    • Study title shortened, about 4 words
  6. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Total morphine consumption within 24h after the surgery.
Timeframe: 24 hours after the surgery.

Secondary (13)

Hyperalgesia - Pressure Pain Threshold
Hyperalgesia - Punctate Pain Intensity
Hyperalgesia - Allodynia zone
Pain intensity
Self reported safety outcomes
Show 8 moreShow less
Measures Safety outcomes
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam-beta-D-glucuronide
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam-N-oxyde
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam-N-demethyl
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of Nefopam hydrochloride
Persistent postoperative pain - DN4 (or DN2 by phone)
Persistent postoperative pain - DN4

Arms and interventions

NEFOPAM 60mg PO/ 8 hoursExperimental

Oral administration of nefopam 60mg 2 hours before the surgery following by 60mg each 8h for 24h.

PlaceboPlacebo comparator

Oral administration of a placebo 2 hours before the surgery following by one administration each 8h for 24h.

Drugs: Oral nefopam, Placebo

Sites

1 site in 1 country

  • Département d'Anesthésie Réanimation, Groupement Hospitalier Nord, Hospices Civils de LyonLyon, France